CIIT vs CYRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CYRX Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CryoPort, Inc. Common Stock (CYRX) driven by superior Valuation, Growth & Margin, Options & Structure while CIIT counters with relative strength in Momentum & Technical. Fundamentally, CIIT trades at N/M Forward P/E with -17.2% operating margin (-2.0% YoY revenue) versus CYRX at 77.5x Forward P/E and -14.4% operating margin (+13.5% YoY). In options structure, CIIT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CYRX sits in BREAKOUT (9th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CIIT Revenue | CYRX Revenue | CIIT Op. Margin | CYRX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $30M | N/A | -52.1% | CYRX |
| FY2020 | N/A | $80M | N/A | -38.1% | CYRX |
| FY2021 | N/A | $220M | N/A | -8.0% | CYRX |
| FY2022 | $0M | $240M | 25.5% | -13.4% | CIIT |
| FY2023 | $0M | $170M | -76.0% | -59.6% | CYRX |
| FY2024 | $10M | $160M | 2.0% | -77.6% | CIIT |
| FY2025 | $10M | $180M | -29.2% | -20.9% | CYRX |
| FY2026 | $10M | N/A | -17.2% | N/A | CIIT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CIIT | CYRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7M | $990.2M | Larger Scale | CYRX |
| Trailing P/E Ratio Valuation | N/M | 77.5x | Lower Multiple | CYRX |
| Forward P/E Ratio Valuation | N/M | 77.5x | Lower Multiple | CYRX |
| Revenue Growth (YoY) Growth | -2.0% | +13.5% | Higher Growth | CYRX |
| Operating Margin (TTM) Profitability | -17.2% | -14.4% | Higher Margin | CYRX |
| Net Profit Margin Profitability | -16.7% | -21.5% | Higher Margin | CIIT |
| Return on Equity (ROE) Capital Efficiency | -57.4% | -7.4% | Higher ROE | CYRX |
| 52-Week Range Position Momentum | 25% ($0โ$5) | 81% ($8โ$22) | Stronger Trend | CYRX |
| Beta / 30D Volatility Risk Regime | -7.63ฮฒ ยท 226% Vol | 1.53ฮฒ ยท 81% Vol | Lower Realized Risk | CYRX |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 52.0 / 100 (HOLD) | Higher Composite | CYRX |